Damora Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMRA and other ETFs, options, and stocks.About DMRA
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2.
DMRA Key Statistics
Stock Snapshot
As of today, Damora Therapeutics(DMRA) shares are valued at $26.46. The company's market cap stands at 35.12M, with a P/E ratio of -2.37.
On 2026-03-10, Damora Therapeutics(DMRA) stock traded between a low of $25.00 and a high of $29.22. Shares are currently priced at $26.46, which is +5.8% above the low and -9.4% below the high.
The Damora Therapeutics(DMRA)'s current trading volume is 86.9K, compared to an average daily volume of 268.83K.
During the past year, Damora Therapeutics(DMRA) stock moved between $2.01 at its lowest and $38.33 at its peak.
During the past year, Damora Therapeutics(DMRA) stock moved between $2.01 at its lowest and $38.33 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.